Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Assessment of the Melanopsin-Containing Retinal Ganglion Cells in Progressive Supranuclear Palsy Using Chromatic Pupillometry

NCT03330353 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03330353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03330353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Assessment of the Melanopsin-Containing Retinal Ganglion Cells in Progressive Supranuclear Palsy Using Chromatic Pupillometry
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2017
Completion date
October 1, 2019
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ad - alzheimer's disease, als (amyotrophic lateral sclerosis), pd - parkinson's disease, psp - progressive supranuclear palsy